Literature DB >> 24824033

Silver nanoparticles: therapeutical uses, toxicity, and safety issues.

Carolina Alves Dos Santos1, Marcelo Martins Seckler2, Avinash P Ingle3, Indarchand Gupta4, Stefania Galdiero5, Massimiliano Galdiero6, Aniket Gade7, Mahendra Rai8.   

Abstract

The promises of nanotechnology have been realized to deliver the greatest scientific and technological advances in several areas. The biocidal activity of Metal nanoparticles in general and silver nanoparticles (AgNPs) depends on several morphological and physicochemical characteristics of the particles. Many of the interactions of the AgNPs with the human body are still poorly understood; consequently, the most desirable characteristics for the AgNPs are not yet well established. Therefore, the development of nanoparticles with well-controlled morphological and physicochemical features for application in human body is still an active area of interdisciplinary research. Effects of the development of technology of nanostructured compounds seem to be so large and comprehensive that probably it will impact on all fields of science and technology. However, mechanisms of safety control in application, utilization, responsiveness, and disposal accumulation still need to be further studied in-depth to ensure that the advances provided by nanotechnology are real and liable to provide solid and consistent progress. This review aims to discuss AgNPs applied in biomedicine and as promising field for insertion and development of new compounds related to medical and pharmacy technology. The review also addresses drug delivery, toxicity issues, and the safety rules concerning biomedical applications of silver nanoparticles.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  antimicrobials; biomaterials; coating; drug delivery; nanotechnology; silver nanoparticles; synthesis; therapeutics; toxicity

Mesh:

Substances:

Year:  2014        PMID: 24824033     DOI: 10.1002/jps.24001

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  72 in total

Review 1.  Impact of nanoparticles on human and environment: review of toxicity factors, exposures, control strategies, and future prospects.

Authors:  Muhammad Sajid; Muhammad Ilyas; Chanbasha Basheer; Madiha Tariq; Muhammad Daud; Nadeem Baig; Farrukh Shehzad
Journal:  Environ Sci Pollut Res Int       Date:  2014-12-30       Impact factor: 4.223

Review 2.  Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.

Authors:  Raziye Mohammadpour; Marina A Dobrovolskaia; Darwin L Cheney; Khaled F Greish; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2019-07-08       Impact factor: 15.470

3.  Novel approach for controlling resistant Listeria monocytogenes to antimicrobials using different disinfectants types loaded on silver nanoparticles (AgNPs).

Authors:  Asmaa Nady Mohammed; Sahar Abdel Aleem Abdel Aziz
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-20       Impact factor: 4.223

4.  Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-β1 secretion.

Authors:  Megan E Martin; Denise K Reaves; Breanna Jeffcoat; Jeffrey R Enders; Lindsey M Costantini; Susan T Yeyeodu; Diane Botta; Terrance J Kavanagh; Jodie M Fleming
Journal:  Nanomedicine       Date:  2019-07-24       Impact factor: 5.307

5.  Calligonum comosum and Fusarium sp. extracts as bio-mediator in silver nanoparticles formation: characterization, antioxidant and antibacterial capability.

Authors:  Afrah E Mohammed; Fadwa F Bin Baz; Jehan S Albrahim
Journal:  3 Biotech       Date:  2018-01-13       Impact factor: 2.406

Review 6.  Silver nanoparticles: synthesis, properties, and therapeutic applications.

Authors:  Liuya Wei; Jingran Lu; Huizhong Xu; Atish Patel; Zhe-Sheng Chen; Guofang Chen
Journal:  Drug Discov Today       Date:  2014-12-24       Impact factor: 7.851

7.  Evaluation of neuroglobin and cytoglobin expression in adult rats exposed to silver nanoparticles during prepubescence.

Authors:  Rodrigo Rodrigues da Conceição; Janaina Sena de Souza; Kelen Carneiro de Oliveira; Renata Marino Romano; Rui Monteiro de Barros Maciel; Magnus Régios Dias-da-Silva; Marco Aurélio Romano; Maria Izabel Chiamolera; Gisele Giannocco
Journal:  Metab Brain Dis       Date:  2019-01-30       Impact factor: 3.584

8.  Exposure to silver nanoparticles primes mast cells for enhanced activation through the high-affinity IgE receptor.

Authors:  Nasser B Alsaleh; Ryan P Mendoza; Jared M Brown
Journal:  Toxicol Appl Pharmacol       Date:  2019-09-05       Impact factor: 4.219

9.  Biosilver nanoparticle interface offers improved cell viability.

Authors:  Sarah Kay VanOosten; Esra Yuca; Banu Taktak Karaca; Kyle Boone; Malcolm L Snead; Paulette Spencer; Candan Tamerler
Journal:  Surf Innov       Date:  2016-11-07       Impact factor: 3.016

10.  Comparative antibacterial activity of silver nanoparticles synthesised by biological and chemical routes with pluronic F68 as a stabilising agent.

Authors:  Carolina Alves Dos Santos; Marcelo Martins Seckler; Avinash P Ingle; Mahendra Rai
Journal:  IET Nanobiotechnol       Date:  2016-08       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.